Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Syntrix Biosystems patents

Patents where

Current Assignee

Name

‌

Syntrix Biosystems

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10993953 Method for treating cancer using chemokine antagonists	Patent 10993953 was granted and assigned to Syntrix Biosystems on May, 2021 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	10993953	May 4, 2021
‌ US Patent 8993541 Aminopyrimidinecarboxamides as CXCR2 modulators	Patent 8993541 was granted and assigned to Syntrix Biosystems on March, 2015 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	8993541	March 31, 2015
‌ US Patent RE48547 Aminopyrimidinecarboxamides as CXCR2 modulators	Patent RE48547 was granted and assigned to Syntrix Biosystems on May, 2021 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	RE48547	May 11, 2021
‌ US Patent 9707248 Use of thiopyrimidinecarboxamide for treating cancer	Patent 9707248 was granted and assigned to Syntrix Biosystems on July, 2017 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	9707248	July 18, 2017
‌ US Patent 10130645 Use of thiopyrimidinecarboxamide for treating cancer	Patent 10130645 was granted and assigned to Syntrix Biosystems on November, 2018 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	10130645	November 20, 2018
‌ US Patent 10046002 Method for treating cancer using chemokine antagonists	Patent 10046002 was granted and assigned to Syntrix Biosystems on August, 2018 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	10046002	August 14, 2018
‌ US Patent 9480694 Thiopyrimidinecarboxamide for use in treating pulmonary disease	Patent 9480694 was granted and assigned to Syntrix Biosystems on November, 2016 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	9480694	November 1, 2016
‌ US Patent RE47415 Pyrimidinecarboxamides as CXCR2 modulators	Patent RE47415 was granted and assigned to Syntrix Biosystems on June, 2019 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	RE47415	June 4, 2019
‌ US Patent RE47740 Aminopyridinecarboxamides as CXCR2 modulators	Patent RE47740 was granted and assigned to Syntrix Biosystems on November, 2019 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	RE47740	November 26, 2019
‌ US Patent 10561676 Method for treating cancer using dual antagonists of CXCR1 and CXCR2	Patent 10561676 was granted and assigned to Syntrix Biosystems on February, 2020 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	10561676	February 18, 2020
‌ US Patent RE47267 Pyridinecarboxamides as CXCR2 modulators	Patent RE47267 was granted and assigned to Syntrix Biosystems on March, 2019 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	RE47267	March 5, 2019
‌ US Patent 8981106 Pyrimidinecarboxamides as CXCR2 modulators	Patent 8981106 was granted and assigned to Syntrix Biosystems on March, 2015 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	8981106	March 17, 2015
‌ US Patent 9000142 Photocleavable sense-antisense complex	Patent 9000142 was granted and assigned to Syntrix Biosystems on April, 2015 by the United States Patent and Trademark Office.		‌ Syntrix Biosystems	United States Patent and Trademark Office	9000142	April 7, 2015
‌ US Patent 9717701 Compositions for overcoming resistance to tramadol	Patent 9717701 was granted and assigned to Syntrix Biosystems on August, 2017 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	9717701	August 1, 2017
‌ US Patent 11000488 Treating pain using desmetramadol	Patent 11000488 was granted and assigned to Syntrix Biosystems on May, 2021 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	11000488	May 11, 2021
‌ US Patent 8969365 Thiopyrimidinecarboxamides as CXCR1/2 modulators	Patent 8969365 was granted and assigned to Syntrix Biosystems on March, 2015 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	8969365	March 3, 2015
‌ US Patent 8748623 Pyridinecarboxamides as CXCR2 modulators	Patent 8748623 was granted and assigned to Syntrix Biosystems on June, 2014 by the United States Patent and Trademark Office.		‌ Syntrix Biosystems	United States Patent and Trademark Office	8748623	June 10, 2014
‌ US Patent 10660909 Method for treating cancer using chemokine antagonists	Patent 10660909 was granted and assigned to Syntrix Biosystems on May, 2020 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	10660909	May 26, 2020
‌ US Patent 9808432 Methods for overcoming resistance to tramadol	Patent 9808432 was granted and assigned to Syntrix Biosystems on November, 2017 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	9808432	November 7, 2017
‌ US Patent 7612071 Compositions and methods employing aminopterin	Patent 7612071 was granted and assigned to Syntrix Biosystems on November, 2009 by the United States Patent and Trademark Office.		‌ Syntrix Biosystems	United States Patent and Trademark Office	7612071	November 3, 2009
‌ US Patent 7312217 Aminopterin dosage forms and methods for inflammatory disorders	Patent 7312217 was granted and assigned to Syntrix Biosystems on December, 2007 by the United States Patent and Trademark Office.		‌ Syntrix Biosystems	United States Patent and Trademark Office	7312217	December 25, 2007
‌ US Patent 8779149 Aminopyridine- and aminopyrimidinecarboxamides as CXCR2 modulators	Patent 8779149 was granted and assigned to Syntrix Biosystems on July, 2014 by the United States Patent and Trademark Office.		‌ Syntrix Biosystems	United States Patent and Trademark Office	8779149	July 15, 2014
‌ US Patent 9717700 Methods for overcoming resistance to tramadol	Patent 9717700 was granted and assigned to Syntrix Biosystems on August, 2017 by the United States Patent and Trademark Office.	‌ Syntrix Biosystems	‌ Syntrix Biosystems	United States Patent and Trademark Office	9717700	August 1, 2017
‌ US Patent 10702485 Compositions and methods for overcoming resistance to tramadol			‌ Syntrix Biosystems	United States Patent and Trademark Office	10702485	July 7, 2020

24 results

0 selected

24 results

0 selected